Stocks
Applied Therapeutics (APLT) EBITDA US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -94.5 | -105.6 | -82.1 | -64.5 | -105.6 | -100.5 | ||
| Changes by years, y/y, % | +108% | +12% | -22% | -21% | +64% | +18.4% | |||
Applied Therapeutics. EBITDA US GAAP, bln rub
Applied Therapeutics. EBITDA US GAAP, changes, %
Applied Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Applied Therapeutics (APLT) EBITDA US GAAP (quarter values) |
||||||||
| FY2024Q3 | FY2024Q4 | FY2025Q1 | FY2025Q2 | FY2025Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -29.6 | 44.1 | -21.8 | -21.3 | -18.9 | -100.5 | |
| Changes by years, y/y, % | +93% | -310% | +3% | +5% | -36% | |||
| Changes by quarters, q/q, % | +46% | -249% | -150% | -2% | -11% | |||
